Signaling Pathways - MDM2 - MK2 - Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) - JAK
清除全部
- A4147 LY2784544Target: Aurora Kinases|FLT3|VEGFR|FGFR|Trk Receptors|JAK|ALK|TYK2|MUSK|MAP3KSummary: JAK2抑制剂
- A4144 AZ 960Target: JAKSummary: JAKs(janus相关激酶)抑制剂
- A4140 WP1066Target: STAT|JAKSummary: 细胞通透的JAK2/STAT3抑制剂。
- A4139 AG-4903 CitationTarget: EGFR|JAKSummary: JAK2/EGFR抑制剂
- A4138 Tofacitinib (CP-690550,Tasocitinib)1 Citation中文名: 托法替尼,托法替布Target: JAKSummary: Janus激酶抑制剂
- A4137 AZD1480Target: JAKSummary: 新型的ATP竞争性JAK2抑制剂
- A4136 TG101348 (SAR302503)2 Citation中文名: 费德拉替尼Target: FLT3|JAK|c-RETSummary: JAK-2抑制剂
- A4135 Tofacitinib (CP-690550) Citrate2 Citation中文名: 托法替尼Target: JAKSummary: JAK抑制剂
- A3012 Ruxolitinib (INCB018424)4 Citation中文名: 鲁索替尼Target: JAKSummary: JAK抑制剂
- N1315 Parthenolide中文名: 小白菊内酯,欧苷菊Target: Histone Deacetylases (HDACs)|MDM2|DNA Methyltransferases|p53|5-HT